09931309 · Active · incorporated 10 years, 7 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
A clinical-stage oncology company developing targeted therapies that exploit DNA damage response (DDR) vulnerabilities in cancer.
See the complete cap table with every shareholder, founder tags, dilution across 39 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.